Marijuana Decriminalization and CBD Bill Tabled in Indiana

January 3, 2020 16:00:29

A wave of cannabis reform has been sweeping through the U.S. for the past few years. After being outlawed for decades, Congress passed the Farm Bill in 2018, legislation that allowed the cultivation of cannabis with less than 0.3% THC levels, terming it industrial hemp. Aside from that, numerous states have taken steps to decriminalize medical and recreational marijuana use, with more progressive legislation passed each year.

This wave of reform hit Indiana after Senator Karen Tallian filed three bills as part of her marijuana reform package in the Senate. One bill would undo a provision in Senate Enrolled Act 516 that outlawed smokable hemp, and another would create a cannabis commission that would regulate the licensing of CBD products in the state. The third bill seeks to decriminalize…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.